[Granulocyte transfusions for severe infections prior to allogeneic hematopoietic stem cell transplantation]
- PMID: 15359916
[Granulocyte transfusions for severe infections prior to allogeneic hematopoietic stem cell transplantation]
Abstract
The efficacy and safety of granulocyte transfusions were evaluated in two acute lymphoblastic leukemia patients for the control of severe infections (cervical cellulitis, sepsis) prior to hematopoietic stem cell transplantation. One patient received 6 transfusions and the other 2 transfusions. The donors were given subcutaneous granulocyte-colony stimulating factor plus oral dexamethasone/betamethasone 12 hours before the scheduled collection. Granulocytes were obtained by standard leukapheresis procedures utilizing hydroxyethyl starch with processing of 7 liters of blood. The yield was 3.2-10.7 x 10(10) (0.7-2.1 x 10(9)/kg of recipient) granulocytes. Post-transfusion increases of peripheral blood neutrophil counts in the following morning were 300 to approximately 6,900/ml. Infections resolved and successful engraftment was obtained in both patients after the transplants. No severe adverse reactions were observed. These findings suggest that granulocyte transfusions are useful for control of severe infections prior to allogeneic hematopoietic stem cell transplantation.
Similar articles
-
Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.Support Care Cancer. 2003 Feb;11(2):101-6. doi: 10.1007/s00520-002-0394-8. Epub 2002 Nov 12. Support Care Cancer. 2003. PMID: 12560938 Clinical Trial.
-
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.Cancer. 2006 Jun 15;106(12):2664-71. doi: 10.1002/cncr.21929. Cancer. 2006. PMID: 16691620
-
Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.Transfusion. 2006 Jan;46(1):14-23. doi: 10.1111/j.1537-2995.2005.00665.x. Transfusion. 2006. PMID: 16398726 Clinical Trial.
-
Granulocyte transfusion: revisited.Curr Hematol Rep. 2003 Nov;2(6):522-7. Curr Hematol Rep. 2003. PMID: 14561398 Review.
-
[Collection of hematopoietic progenitor cells from healthy donors].Acta Med Croatica. 2009 Jun;63(3):237-44. Acta Med Croatica. 2009. PMID: 19827352 Review. Croatian.
Publication types
MeSH terms
LinkOut - more resources
Medical